- <![CDATA[Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer]]><![CDATA[Capivasertib plus fulvestrant generated a numerical OS benefit vs placebo plus fulvestrant in PIK3CA/AKT1/PTEN-altered advanced breast cancer.]]>onclive · 2mo ago↗ source
- <![CDATA[FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinoma ]]><![CDATA[]]>onclive · 2mo ago↗ source
- Trump plans to fire Makary from FDA role, according to reportsFDA Commissioner Marty Makary is expected to be fired from his role, according to multiple media reports. The plans haven’t been finalized and could still change, said the Wall Street Journal ...Endpoints · 2mo ago↗ source